Middle East and Africa Prebiotics for Infant Formula Market - Industry Trends and Forecast To 2027

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 DBMR MARKET POSITION GRID

2.7 MULTIVARIATE MODELING

2.8 PRODUCT TIMELINE CURVE

2.9 SECONDARY SOURCES

2.10 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 EVOLUTION

5.1 EVOLUTION OF INFANT FORMULA

5.2 EVOLUTION OF PREBIOTICS FORMULA

6 REGULATIONS & QUALITY REQUIREMENTS

6.1 REGULATIONS

6.1.1 FDA

6.1.1.1 GRAS NOTICE NO. GRN 000849

6.1.1.2 GRAS NOTICE NO. GRN 00859

6.1.1.3 GRAS NOTICE NO. GRN 000797

6.1.1.4 GRAS NOTICE NO. GRN 000766

6.1.1.5 GRAS NOTICE NO. GRN 000749

6.1.1.6 GRAS NOTICE NO. GRN 000735

6.1.1.7 GRAS NOTICE NO. GRN 000729

6.1.1.8 GRAS NOTICE NO. GRN 000717

6.1.1.9 GRAS NOTICE NO. GRN 000721

6.1.1.10 GRAS NOTICE NO. GRN 000659

6.1.1.11 GRAS NOTICE NO. GRN 000650

6.1.1.12 GRAS NOTICE NO. GRN 000623

6.1.1.13 GRAS NOTICE NO. GRN 000620

6.1.2 EUROPEAN UNION

6.1.2.1 COMMISSION DIRECTIVE 2006/141/EC

6.1.3 AUSTRALIA NEW ZEALAND FOOD STANDARDS CODE

6.1.3.1 STANDARD 2.9.1

6.1.3.2 STANDARD 2.9.2

6.1.3.3 STANDARD 2.9.3

6.2 QUALITY REQUIREMENTS

7 CLINICAL TRIALS

7.1 NCT03994315

7.2 NCT03884309

7.3 NCT02594683

7.4 NCT03661736

7.5 NCT03666572

7.6 NCT03866837

7.7 NCT03476889

8 INFANT FORMULA BRAND ANALYSTS

8.1 ABBOTT

8.2 MEAD JOHNSON & COMPANY, LLC

8.3 DANONE NUTRICIA

8.4 NESTLE

8.5 PERRIGO NUTRITIONALS

8.6 HOCHDORF HOLDING AG

9 MARKET OVERVIEW

9.1 DRIVERS

9.1.1 RISING NUMBER FROM PRETERM/PREMATURE BABIES

9.1.2 INCREASED RESEARCH INITIATIVE FOR NEW PRODUCT DEVELOPMENT

9.1.3 HEALTH BENEFITS ASSOCIATED WITH PREBIOTICS

9.1.4 GROWING CONCERN AND DEMAND FOR THE HEALTHY BABY FOOD

9.1.5 RISING POPULATION OF INFANT

9.2 RESTRAINTS

9.2.1 STRINGENT REGULATION AND APPROVAL CRITERIA SET BY GOVERNMENTS

9.2.2 RISING AWARENESS TOWARDS MOTHER FEEDING FOR INFANT

9.3 OPPORTUNITIES

9.3.1 RAPID DEVELOPMENT IN CHICORY ROOT BASED PREBIOTICS

9.3.2 EMERGING DEMAND IN DEVELOPING NATIONS

9.3.3 STRENGTHENING TRADE RELATIONSHIP BETWEEN DIFFERENT NATIONS

9.4 CHALLENGE

9.4.1 RISING NUMBER OF PRODUCT RECALLS FOR INFANT FORMULA DUE TO CONTAMINATION

10 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE

10.1 OVERVIEW

10.2 HUMAN MILK OLIGOSACCHARIDES (HMOS)

10.2.1 FUCOSYLLACTOSE

10.2.1.1 NEUTRAL FUCOSYLATE OLIGOSACCHARIDES

10.2.1.2 NON-FUCOSYLATED OLIGOSACCHARIDES

10.2.2 LACTO-N- TETRAOSE (LNT) & LACTO-N-NEOTETRAOSE (LNNT)

10.2.3 SIALYLLACTOSE

10.3 FRUCTOOLIGOSACCHARIDES (FOS)

10.3.1 LONG CHAIN FOS (LCFOS)

10.3.2 SINGLE CHAIN FOS (SCFOS)

10.4 GALACTOOLIGOSACCHARIDES (GOS)

10.4.1 LACTOSE DERIVED

10.4.2 GALACTOSE DERIVED

10.5 INULIN

10.6 POLYDEXTROSE (PDX)

10.7 MANNAN-OLIGOSACCHARIDES (MOS)

10.8 LACTULOSE (LOS)

11 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE

11.1 OVERVIEW

11.2 PLANTS & VEGETABLES

11.2.1 WHEAT

11.2.2 CHICORY ROOT

11.2.3 BANANAS

11.2.4 LEEKS

11.2.5 TOMATOES

11.2.6 OTHERS

11.3 BACTERIA

11.4 FUNGI

11.5 ALGAE

11.6 OTHERS

12 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE

12.1 OVERVIEW

12.2 INORGANIC

12.3 ORGANIC

13 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM

13.1 OVERVIEW

13.2 POWDER

13.3 LIQUID

14 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE

14.1 OVERVIEW

14.2 STANDARD FORMULA

14.3 SPECIAL FORMULA

14.4 FOLLOW UP FORMULA

14.5 TODDLER FORMULA

15 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE

15.1 OVERVIEW

15.2 6-12 MONTHS

15.3 0-6 MONTHS

15.4 1-3 YEARS

16 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY GEOGRAPHY

16.1 MIDDLE EAST & AFRICA

16.1.1 SOUTH AFRICA

16.1.2 U.A.E.

16.1.3 SAUDI ARABIA

16.1.4 OMAN

16.1.5 KUWAIT

16.1.6 REST OF MIDDLE EAST & AFRICA

17 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

18 COMPANY PROFILE

18.1 ROYAL FRIESLANDCAMPINA N.V.

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 COMPANY SHARE ANALYSIS

18.1.4 PRODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENTS

18.2 CARGILL, INCORPORATED.

18.2.1 COMPANY SNAPSHOT

18.2.2 REVENUE ANALYSIS

18.2.3 COMPANY SHARE ANALYSIS

18.2.4 PRODUCT PORTFOLIO

18.2.5 RECENT DEVELOPMENT

18.3 INGREDION INCORPORATED

18.3.1 COMPANY SNAPSHOT

18.3.2 REVENUE ANALYSIS

18.3.3 COMPANY SHARE ANALYSIS

18.3.4 PRODUCT PORTFOLIO

18.3.5 RECENT DEVELOPMENT

18.4 BENEO (A SUBSIDIARY OF SÜDZUCKER)

18.4.1 COMPANY SNAPSHOT

18.4.2 REVENUE ANALYSIS

18.4.3 COMPANY SHARE ANALYSIS

18.4.4 PRODUCT PORTFOLIO

18.4.5 RECENT DEVELOPMENTS

18.5 FONTERRA CO-OPERATIVE GROUP

18.5.1 COMPANY SNAPSHOT

18.5.2 REVENUE ANALYSIS

18.5.3 COMPANY SHARE ANALYSIS

18.5.4 PRODUCT PORTFOLIO

18.5.5 RECENT DEVELOPMENTS

18.6 BIOSYNTH CARBOSYNTH

18.6.1 COMPANY SNAPSHOT

18.6.2 PRODUCT PORTFOLIO

18.6.3 RECENT DEVELOPMENTS

18.7 COSUCRA

18.7.1 COMPANY SNAPSHOT

18.7.2 PRODUCT PORTFOLIO

18.7.3 RECENT DEVELOPMENTS

18.8 DANA DAIRY GROUP

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENTS

18.9 DEXTRA LABORATORIES LIMITED

18.9.1 COMPANY SNAPSHOT

18.9.2 PRODUCT PORTFOLIO

18.9.3 RECENT DEVELOPMENT

18.10 DUPONT.

18.10.1 COMPANY SNAPSHOT

18.10.2 REVENUE ANALYSIS

18.10.3 PRODUCT PORTFOLIO

18.10.4 RECENT DEVELOPMENTS

18.11 ELICITYL SA

18.11.1 COMPANY SNAPSHOT

18.11.2 PRODUCT PORTFOLIO

18.11.3 RECENT DEVELOPMENT

18.12 GLYCOM A/S

18.12.1 COMPANY SNAPSHOT

18.12.2 PRODUCT PORTFOLIO

18.12.3 RECENT DEVELOPMENT

18.13 GLYCOSYN LLC.

18.13.1 COMPANY SNAPSHOT

18.13.2 PRODUCT PORTFOLIO

18.13.3 RECENT DEVELOPMENTS

18.14 JENNEWEIN BIOTECHNOLOGIE GMBH

18.14.1 COMPANY SNAPSHOT

18.14.2 PRODUCT PORTFOLIO

18.14.3 RECENT DEVELOPMENTS

18.15 NEW FRANCISCO (YUNFU CITY) BIOTECHNOLOGY CORPORATION LIMITED

18.15.1 COMPANY SNAPSHOT

18.15.2 PRODUCT PORTFOLIO

18.15.3 RECENT DEVELOPMENTS

18.16 ROYAL COSUN

18.16.1 COMPANY SNAPSHOT

18.16.2 REVENUE ANALYSIS

18.16.3 APPLICATION PORTFOLIO

18.16.4 RECENT DEVELOPMENT

18.17 TEREOS

18.17.1 COMPANY SNAPSHOT

18.17.2 REVENUE ANALYSIS

18.17.3 PRODUCT PORTFOLIO

18.17.4 RECENT DEVELOPMENT

18.18 ZUCHEM INC.

18.18.1 COMPANY SNAPSHOT

18.18.2 PRODUCT PORTFOLIO

18.18.3 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

UU

TABLE 1 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 2 MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 3 MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 4 MIDDLE EAST & AFRICA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA INULIN IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA POLYDEXTROSE (PDX) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA MANNAN-OLIGOSACCHARIDES (MOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA LACTULOSE (LOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA BACTERIA IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA FUNGI IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA ALGAE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA OTHERS IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA INORGANIC IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA ORGANIC IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA POWDER IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA LIQUID IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA STANDARD FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA SPECIAL FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA FOLLOW UP FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA TODDLER FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA 6-12 MONTHS IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA 0-6 MONTHS IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA 1-3 YEARS IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 47 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 48 SOUTH AFRICA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 49 SOUTH AFRICA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 50 SOUTH AFRICA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 51 SOUTH AFRICA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 52 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 53 SOUTH AFRICA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 54 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 55 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 56 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 57 SOUTH AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 58 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 59 U.A.E. HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 60 U.A.E. FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 61 U.A.E. GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 62 U.A.E. FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 63 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 64 U.A.E. PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 65 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 66 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 67 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 68 U.A.E. PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 69 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 70 SAUDI ARABIA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 71 SAUDI ARABIA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 72 SAUDI ARABIA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 73 SAUDI ARABIA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 74 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 75 SAUDI ARABIA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 76 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 77 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 78 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 79 SAUDI ARABIA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 80 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 81 OMAN HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 82 OMAN FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 83 OMAN GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 84 OMAN FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 85 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 86 OMAN PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 87 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 88 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 89 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 90 OMAN PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 91 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 92 KUWAIT HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 93 KUWAIT FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 94 KUWAIT GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 95 KUWAIT FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 96 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 97 KUWAIT PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 98 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 99 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 100 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 101 KUWAIT PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 102 REST OF MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)